Schisantherin CCAS# 64938-51-8 |
| Cas No. | 64938-51-8 | SDF | File under preparation. |
| PubChem ID | 6443826 | Appearance | Powder |
| Formula | C28H34O9 | M.Wt | 514.6 |
| Type of Compound | Lignans | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC=C(C)C(=O)OC1C2=CC(=C(C(=C2C3=C(C4=C(C=C3CC(C1(C)O)C)OCO4)OC)OC)OC)OC | ||
| Standard InChIKey | BKGUPIVDQHHVMV-LSHKVNPSSA-N | ||
| Standard InChI | InChI=1S/C28H34O9/c1-9-14(2)27(29)37-26-17-12-18(31-5)22(32-6)25(34-8)21(17)20-16(10-15(3)28(26,4)30)11-19-23(24(20)33-7)36-13-35-19/h9,11-12,15,26,30H,10,13H2,1-8H3/b14-9+/t15-,26-,28-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock

Number of papers citing our products

| Description | 1. Schisantherin A, B, C, and D show good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis. |
Schisantherin C Dilution Calculator
Schisantherin C Molarity Calculator
-
Schisantherin BCatalog No.: BCN1023CAS No.: 58546-55-7 -
Schisanwilsonin ICatalog No.: BCN5548CAS No.: 1181216-84-1 -
Tigloylgomisin PCatalog No.: BCN6926CAS No.: 69176-51-8 -
Gomisin FCatalog No.: BCN3625CAS No.: 62956-47-2 -
Angeloylgomisin QCatalog No.: BCN7033CAS No.: 72561-28-5 -
Schisantherin ACatalog No.: BCN1024CAS No.: 58546-56-8 -
Schisanwilsonin HCatalog No.: BCN3315CAS No.: 1181216-83-0 -
Benzoylgomisin PCatalog No.: BCN8803CAS No.: 129445-43-8 -
Angeloylgomisin OCatalog No.: BCN7361CAS No.: 83864-69-1 -
Tigloylgomisin OCatalog No.: BCN8880CAS No.: 130855-74-2 -
Gomisin GCatalog No.: BCN2269CAS No.: 62956-48-3 -
Angeloylisogomisin OCatalog No.: BCN4379CAS No.: 83864-70-4 -
Heteroclitin BCatalog No.: BCN3745CAS No.: 140461-47-8 -
Heteroclitin CCatalog No.: BCN3632CAS No.: 140460-42-0 -
Schisantherin DCatalog No.: BCN7010CAS No.: 64917-82-4 -
Interiotherin CCatalog No.: BCN3636CAS No.: 460090-65-7
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9433 mL | 9.7163 mL | 19.4326 mL | 38.8651 mL | 48.5814 mL |
| 5 mM | 0.3887 mL | 1.9433 mL | 3.8865 mL | 7.773 mL | 9.7163 mL |
| 10 mM | 0.1943 mL | 0.9716 mL | 1.9433 mL | 3.8865 mL | 4.8581 mL |
| 50 mM | 0.0389 mL | 0.1943 mL | 0.3887 mL | 0.7773 mL | 0.9716 mL |
| 100 mM | 0.0194 mL | 0.0972 mL | 0.1943 mL | 0.3887 mL | 0.4858 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
- Sendanolactone
Catalog No.:BCN4193
CAS No.:64929-59-5
- Schisantherin E
Catalog No.:BCN6766
CAS No.:64917-83-5
- Schisantherin D
Catalog No.:BCN7010
CAS No.:64917-82-4
- Boc-D-Trp(For)-OH
Catalog No.:BCC2598
CAS No.:64905-10-8
- BAY 61-3606 dihydrochloride
Catalog No.:BCC1407
CAS No.:648903-57-5
- trans-Norpterosin C
Catalog No.:BCN6918
CAS No.:64890-70-6
- Urapidil HCl
Catalog No.:BCC5044
CAS No.:64887-14-5
- Rubusoside
Catalog No.:BCN2313
CAS No.:64849-39-4
- AS-605240
Catalog No.:BCC2495
CAS No.:648450-29-7
- AS-604850
Catalog No.:BCC4989
CAS No.:648449-76-7
- ophocarpine hydrobromide
Catalog No.:BCN7541
CAS No.:78003-71-1
- Vitexin-2''-O-rhamnoside
Catalog No.:BCN5025
CAS No.:64820-99-1
- Ditryptophenaline
Catalog No.:BCN7408
CAS No.:64947-43-9
- H-D-Asp(OtBu)-OH
Catalog No.:BCC2899
CAS No.:64960-75-4
- Brivanib (BMS-540215)
Catalog No.:BCC1231
CAS No.:649735-46-6
- Brivanib Alaninate (BMS-582664)
Catalog No.:BCC1240
CAS No.:649735-63-7
- Pifithrin-μ
Catalog No.:BCC2412
CAS No.:64984-31-2
- 7alpha-Hydroxystigmasterol
Catalog No.:BCN4194
CAS No.:64998-19-2
- 1-Testosterone
Catalog No.:BCC8474
CAS No.:65-06-5
- Yohimbine Hydrochloride
Catalog No.:BCN6268
CAS No.:65-19-0
- Pyridoxine
Catalog No.:BCC8355
CAS No.:65-23-6
- Phentolamine Mesylate
Catalog No.:BCC4353
CAS No.:65-28-1
- Gallamine Triethiodide
Catalog No.:BCC4576
CAS No.:65-29-2
- Nicotine Difartrate
Catalog No.:BCC3821
CAS No.:65-31-6
Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds.[Pubmed:233922]
Sci Sin. 1978 Jul-Aug;21(4):483-502.
Deoxyschisandrin (VIII) and five new lignans, named schisantherin A, B, C, D, and E, were isolated from the active fraction of the fruits of Schisandra sphenanthera Rehd. et Wils. Their configurations and conformations were established by exhaustive spectral analysis as well as chemical degradations as shown in Ia, Ib; IIa, IIb; IIIa, IIIb; IVa, IVb, and Va, Vb respectively, and their absolute configurations at biphenyl, at C6, C7, and C8 were all assigned to be S form. The position of the methylenedioxyl group in the structures of gamma-schisandrin and Wuweizisu C (as described in the literature), isolated from Schisandra chinensis, must be corrected as shown in VI and VII respectively. In pharmacologica studies and preliminary clinical trials, schisantherin A, B, C, and D showed good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis. Schisantherin E and deoxyschisandrin were not effective.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University


